Thank you, C2C4C United States Riders!

V Foundation-funded researcher Megan Ruhland, Ph.D., from Knight Cancer Institute at Oregon Health and Science University and Javier Gordon Ogembo, Ph.D., from City of Hope Comprehensive Cancer Center provide encouraging words for the Bristol Myers Squibb C2C4C United States riders who are cycling cross-country to fundraise for the V Foundation for cancer research.

The 2026 ride kicks off on September 10 in Cannon Beach, Oregon, with over 100 Bristol Myers Squibb employees covering nearly 3,000 miles throughout the 27-day journey. Together, their goal is to raise $1 million for game-changing cancer research through the V Foundation.